Advertisement

Topics

Companies Related to "Related Macular Degeneration Pipeline Review 2017 Report Updated" [Most Relevant Company Matches] - Page: 2 RSS

22:17 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Related Macular Degeneration Pipeline Review 2017 Report Updated" found in our extensive corporate database of over 50,000 company records.

Showing "Related Macular Degeneration Pipeline Review 2017 Report Updated" Companies 26–50 of 3,200+

Relevant

ArcticDx, Inc.

ArcticDx Inc. is a molecular diagnostic company with expertise in the design, development and commercialization of validated prognostic and pharmacogenetic tests for significant diseases including age-related macular degeneration (AMD). Our business model is focused towards the rapid commercialization of Intellectual Property (IP) from international gene d...


SOOFT italia S.p.A.

SOOFT italia S.p.A. a Company of OOgroup , is an Italian pharmaceutical firm specialized in the research of new solutions , in carrying out and marketing of products for general and specific eyes health.SOOFT italia S.p.A. is mainly involved in the most common ocular pathologies, ranging from anterior segment (dry eye, ocular inflammations, periocular hygi...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalmology to support patients who are at risk of blindness or suffering from vision impairment, and to serve the health care professionals who treat them. Its current product line includes the most presc...


Acucela Inc

Acucela Inc. is a biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people worldwide, and there is a drastic lack of therapies available. Until now, ophthalmic drug discovery technologies have been very limi...

Neurotech Pharmaceuticals, Inc.

Neurotech is developing sight-saving therapeutics for the treatment of chronic retinal diseases. The Company's lead product candidate, NT-501, is currently in late-stage clinical development for advanced dry age-related macular degeneration (dry AMD) and retinitis pigmentosa (RP). The Company's portfolio of product candidates also includes treatments for wet AMD. All of Neurotech's development pro...

EyeScience

EyeScience is a privately held company that develops and markets the most complete, physician-created, clinically proven vitamins and supplements to treat macular degeneration and dry eye. EyeScience's products, developed by ophthalmologists, optometrists and nutritionists, offer the most innovative, science-based supplements available on the market.

MeiraGTx

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomi...

Expert Opinion

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.

MeiraGTx Limited

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomi...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The company’s orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acui...

eMedicine.com, Inc

Launched in 1996, www.eMedicine.com comprises the largest and most current Clinical Knowledge Base available to physicians and other healthcare professionals. eMedicine's subscription site for institutions is www.iMedicine.com. Nearly 10,000 physician authors and editors contribute to the eMedicine Clinical Knowledge Base, which contains articles on 7,000 diseases and disorders. The evidence-based...

Regeneron Pharmaceuticals, Inc.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-re...

Moran Eye Center

The Moran Eye Center is the largest eye care and vision research center in the Intermountain West, and is part of the University of Utah Hospitals and Clinics. With collaborators from around the world, research advancements provide new diagnoses, novel treatments and creative new procedures designed to cure blinding eye diseases. Treatments and procedures ...

The Moran Eye Center

The Moran Eye Center is the largest eye care and vision research center in the Intermountain West and is part of the University of Utah Hospitals and Clinics. With collaborators from around the world, research advancements at the center provide new diagnoses, novel treatments, and creative new procedures designed to cure blinding eye diseases. Treatments a...

Vitro Diagnostics

We develop stem cell technology for potential use in diabetes research and treatment. Our research has led to a patent-pending method for generation of adult stem cells from cells isolated from tissues. While embryonic stem cells are capable of differentiation into all of the various cells of the body, adult stem cells are more limited in differentiation capacity generally including the cell typ...

Informa Healthcare - Expert Opinion series

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs

RetroSense Therapeutics LLC.

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. There are currently no FDA-approved drugs to improve or restore vision in patients with these retinal degene...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to detect clinically with conventional examination equipment and techniques. Optos' devices produce ultra wide-field, high-resolution images of approximately 82% of the retina, somethi...

Altris.AI

Altris.AI (Altris, Inc) is a company which applies computer vision and deep learning trained algorithms to build innovative ophthalmology diagnosis real-time support platform for the automatic, structural and quantitative analysis and detection of glaucoma, age-related macular degeneration, diabetic retinopathy and other retinal diseases on Optical Coheren...

Notogen Inc.

Notogen is a biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine. Notogen’s lead candidate, NTG-101, is a targeted, non-surgical, non-cellular protein-based biologic for the treatment of disc degeneration disease. The product is in pre-clinical development and is cur...

Eyenuk Inc.

Eyenuk Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology...

BioTime, Inc. 

BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical programs are targeting three primary sectors, aesthetics, ophthalmology and cell and drug delivery. Its clinical programs are based on two platform technologies: pluripotent cells...

ReVision Therapeutics Inc.

ReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small molecule drug for the treatment and prevention of the dry form of age-related macular degeneration (AMD). Fenretinide (RT-101), ReVision's lead drug candidate, has been evaluated in a Phase 2b clinical trial in patients with geographic atrophy, the most advanced form of dry AMD. Analysis of the end-of-st...

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and covering 35 states plus the District of Columbia, each report provides a detailed look at:

Imagen Biotech, Inc.

Imagen Biotech, Inc. is a private, venture-backed biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Since its formation in the summer of 2011 with financing from SV Life Sciences, Novo Ventures and Fidelity Biosciences, Imagen con...


More From BioPortfolio on "Related Macular Degeneration Pipeline Review 2017 Report Updated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks